- Home
- DNA vs SANA Comparison
DNA vs SANA Comparison
Compare DNA & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNA
- SANA
- Stock Information
- Founded
- DNA 2008
- SANA 2018
- Country
- DNA United States
- SANA United States
- Employees
- DNA N/A
- SANA N/A
- Industry
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- SANA Medicinal Chemicals and Botanical Products
- Sector
- DNA Health Care
- SANA Health Care
- Exchange
- DNA Nasdaq
- SANA Nasdaq
- Market Cap
- DNA 895.1M
- SANA 983.4M
- IPO Year
- DNA N/A
- SANA 2021
- Fundamental
- Price
- DNA $13.23
- SANA $5.75
- Analyst Decision
- DNA Strong Sell
- SANA Strong Buy
- Analyst Count
- DNA 1
- SANA 6
- Target Price
- DNA $9.00
- SANA $8.00
- AVG Volume (30 Days)
- DNA 1.8M
- SANA 6.2M
- Earning Date
- DNA 11-11-2025
- SANA 11-07-2025
- Dividend Yield
- DNA N/A
- SANA N/A
- EPS Growth
- DNA N/A
- SANA N/A
- EPS
- DNA N/A
- SANA N/A
- Revenue
- DNA $230,815,000.00
- SANA N/A
- Revenue This Year
- DNA N/A
- SANA N/A
- Revenue Next Year
- DNA $14.41
- SANA N/A
- P/E Ratio
- DNA N/A
- SANA N/A
- Revenue Growth
- DNA 25.21
- SANA N/A
- 52 Week Low
- DNA $5.00
- SANA $1.26
- 52 Week High
- DNA $17.58
- SANA $7.30
- Technical
- Relative Strength Index (RSI)
- DNA 48.01
- SANA 69.93
- Support Level
- DNA $13.16
- SANA $4.81
- Resistance Level
- DNA $16.50
- SANA $6.55
- Average True Range (ATR)
- DNA 1.46
- SANA 0.54
- MACD
- DNA -0.22
- SANA 0.14
- Stochastic Oscillator
- DNA 15.37
- SANA 71.25
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.